Approximately one-third of infants with ROP (334, 34.0%) received ROP treatment, including laser photocoagulation alone (219, 65.6% among those with treated ROP), anti-VEGF therapy alone (63, 18.9%), or both treatments (52, 15.6%). Here, VEGFA is linked to retinopathy of prematurity.